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Viral reactivation(IFNγ) plays during herpetic stromal keratitis (HSK) has not been deﬁnitively
determined. In primary HSK most reports suggest that IFNγmay help control viral replication and contribute
to corneal pathology. However, its role in recurrent HSK has not been directly addressed. The present study
addresses its role in recurrent HSK by comparing HSK in latently infected normal and IFNγ gene knockout
(GKO) on the C57BL/6 background. We initially evaluated HSK following primary infection and observed that
GKO mice had higher tear ﬁlm virus titers, but virtually identical ocular disease as normal mice. In contrast,
following reactivation of latent virus, GKO mice had a greater incidence and severity of opacity,
neovascularization, and blepharitis. Interestingly, the incidence of reactivation after UV-B exposure was
equivalent in GKO and normal mice, but virus shedding was increased in the GKO groups. We also observed
diminished delayed-type hypersensitivity responses in GKO mice, as expected. These data indicate that IFNγ
is important for the control of virus replication in both primary and recurrent ocular HSV infection in C57BL/6
mice. The enhanced recurrent disease seen in GKO mice may be the result of increased viral titers and
persistence in these mice which act to prolong the stimulation of an inﬂammatory response.
© 2008 Elsevier Inc. All rights reserved.Introduction
Herpetic stromal keratitis (HSK) is a potentially blinding corneal
inﬂammation that accompanies herpes simplex virus (HSV) infection of
the eye. The disease course in HSK begins with a primary infection by
HSV followed by a period during which the virus enters latency in
sensory and autonomic ganglia. Many studies have shown that clinical
manifestations of the disease are the result of a cocktail of inﬂammatory
cells, consistingof PMN's,macrophages andTcells (bothCD4+ and CD8+)
(Maertzdorf et al., 2003; Pepose et al., 1996; Thomas and Rouse, 1997;
Youinou et al., 1985, 1986). These cells are recruited to the site of
infection by the release of inﬂammatory factors, including cytokines and
chemokines (Maertzdorf et al., 2002; Su et al.,1996; Thomas et al.,1998).
Once there, these cells appear to be responsible for the majority of
corneal damage (Streilein et al., 1997). Primary models of this disease
have indicated that the process resulting in corneal damage is due to the
presence of CD4+ Th1 whose cytokines dominate during the preclinical
and clinical phases of acute HSK (Niemialtowski and Rouse 1992;
Thomaset al.,1998). These cytokines include IL-2, IL-12, and IFN-γ (Babu
et al., 1995; Thomas et al., 1998; He et al., 1999).ology and Visual Sciences,
6, St. Louis, MO 63110, USA.
).
l rights reserved.Studies addressing the role that these Th1 cytokines play following
HSV-1 infection can be categorized in two ways: Survival of the
animal, in which IFNγ plays a minor role that is subordinate to that
played by type 1 interferons (Ghiasi et al., 2000; Vollstedt et al., 2004)
Secondly, evaluation of corneal disease has indicated that IL-12 and
IFNγ are not only found early in infection (Stumpf et al., 2002; Thomas
et al., 1998), but that targeting them signiﬁcantly altered disease
(Bouley et al., 1995; Lee et al., 2002; Osorio et al., 2002). Thus, during
acute ocular HSV infection, treatment of mice with neutralizing anti-
IFNγ antibodies resulted in diminished HSK lesions (Hendricks et al.,
1992; Smith et al., 1994). In contrast, a study of primary infection in
IFNγ knock out (GKO) mice showed that HSK lesions may be
generated in the absence of IFNγ, potentially due to the inﬂuence of
other pro-inﬂammatory cytokines or the prolonged presence of the
virus itself (Bouley et al., 1995).
However these reports have been restricted to primary models of
disease. Interestingly, HSK in humans most often occurs long after
primary infection abates, when reactivated virus returns to the eye
from latency sites in neuronal tissues (Miller et al., 1996; Rinne et al.,
1992). Renewed virus presence in the cornea initiates a recurrent HSK
response, with the potential to cause impaired vision, including
permanent corneal opacities and neovascularization. It has previously
been reported that IFNγ and TNF-α are found in infected trigeminal
ganglia in both humans (Theil et al., 2003) and mice (Liu et al., 1996).
The role of these cytokines in the trigeminal ganglia is one of
maintenance of latency (Liu et al., 2001; Khanna et al., 2003). However
Fig. 2. Delayed-type hypersensitivity (DTH) responses 2 weeks following primary
infection with HSV-1. Following HSV-1 infection, mice were tested for DTH responses.
The numbers of mice used in this study were as follows: B6 infected, n=20; B6 naive,
n=5; GKO infected, n=20; GKO, n=5. Results indicate mean±SEM. *P=0.004 infected
vs. naive. **P=0.009 infected B6 vs. infected GKO. ***Pb0.001 infected vs. naive.
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wild-typemice (Ellison et al., 2000). Studies investigating reactivation,
both in humans and mice have shown that both the cells and the
cytokines found in corneas display a mixed phenotype, namely that
both Th1 and Th2 cytokines are present, though theremight be slightly
more Th1 cells than Th2 cells (He et al., 1999; Keadle et al., 2001;
Stumpf et al., 2001). However, when it comes to evaluation of the role
these cytokines play during recurrent disease, there is a paucity of
information. Hence, our desire was to address the role that these
cytokines play during recurrent HSK in mice. We previously reported
that both TNF-α and IL-1 are required for recurrent HSK (Keadle et al.,
2000). More recently we reported that IL-10 appears to be involved in
ameliorating recurrent disease (Keadle and Stuart, 2005).
Due to the role that IFNγ seems to play in primary HSK as well as
maintenance of latency, we wanted to determine what role it plays
during recurrent HSK. IFNγ is a multifunctional cytokine with anti-
viral and pro-inﬂammatory properties that may contribute to the
ocular pathology observed during primary HSK. Since recurrent HSK
has the greatest potential to cause blindness in humans, this work
examines the role of IFNγ in a mouse model of recurrent HSK utilizing
GKO mice (Laycock et al., 1991). We present data demonstrating that
in contrast to what has been reported during primary disease, GKO
mice display increased severity of ocular disease following UV-B
induced reactivation of latently infected mice. We also demonstrate
that viral titers were increased for GKO mice and that virus persisted
in these mice longer than in wild-type mice. These data suggest that
recurrent HSK in GKO mice might be the result of viral persistence.
Results
Previous studies investigating the role that IFNγ plays during
primary HSK used C.129S7 (B6)-Ifngtm1Ts/J (Bouley et al., 1995), whichFig. 1. Corneal disease in B6 mouse strains lacking IFNγ following HSV-1 infection.
Following infection, mice were monitored for corneal opacity (A) corneal neovascular-
ization (B) and blepharitis for 32 days. The numbers of mice used for these studies were
as follows: B6, n=20; GKO, n=20. Results indicate mean±SEM. *Pb.05. ○, B6; ●, GKO.is on the HSV-sensitive BALB/C background. And since Lekstrom-
Himes' study using the same strain of GKO mice that we did, did not
examine clinical disease (Lekstrom-Himes et al., 2000), we decided to
perform an examination of primary HSK in normal and GKO mice on
the C57/BL6 background. Post infection corneal opacity tended to be
greater in normal B6mice than in GKOmice, but it was not statistically
signiﬁcant (Fig. 1A). Neovascularization was indistinguishable
between normal and GKO mice (Fig. 1B). Blepharitis scores wereFig. 3. Corneal disease in B6 mouse strains lacking IFNγ following UV-B induced
reactivation. Latently infected mice were induced to reactivate with UV-B irradiation
and mice were monitored for corneal opacity (A) and corneal neovascularization (B) for
38 days. The numbers of mice used for these studies were as follows: B6, n=35; GKO,
n=30. Results indicate mean±SEM. *There was signiﬁcant virus-induced disease
(compared to strain matched uninfected UV-B controls) in GKO eyes for days 3–16 in
corneal opacity and days 8–38 for neovascularization (P=0.001 to 0.01). There was
signiﬁcant virus-induced disease in B6 mice only on days 3 and 8 for corneal opacity
(Pb0.02) and none for neovascularization. Disease scores for infected GKO mice
exceeded those of infected B6 mice on days 3–16, 32 for corneal opacity (Pb0.001 to
0.05) and days 8, 16, 32, 38 for neovascularization (Pb0.001 to 0.05). Incidence of
corneal opacity score N1 was: GKO-31%, normal=9% (P=0.02). Incidence for
neovascularization scores N1 was: GKO=50%, normal=24% (P=0.02). ○, B6 control; ●,
B6 latently infected; □, GKO control; ■, GKO latently infected.
Fig. 4. Blepharitis in B6mouse strains lacking IFNγ following UV-B induced reactivation.
Latently infected mice were induced to reactivate with UV-B irradiation and scored for
blepharitis (A) and percent mice showing positive blepharitis (B) for 32 days. The
numbers of mice used for these studies were as follows: B6, n=35; GKO, n=30. Results
indicate mean±SEM. GKO mice displayed signiﬁcantly greater blepharitis scores and
incidence than normal B6mice, which did not display signiﬁcant blepharitis above their
UV-B controls, for days 8 to 23 (Pb.001 to 0.03).○, B6 control;●, B6 latently infected;□,
GKO control; ■, GKO latently infected.
Table 1
HSV-1 shedding following UV-B reactivation
Normal C57BL/6 γKO C57BL/6
EYESa
3 Days Plb (n) 1367+567 (21) 695+158 (27)
Post react peakc (n) 1716+781 (16) 44,643+15,593 (24)d
Days sheddinge 2.0+0.3 3.88+0.4f
% Reactivation rate 60% (21+/35 total) 80% (24+/30 total)
Trigeminal gangliag
Days to positive (n)h 4.5+0.3 (4) 4+0 (3)
PFU/TG at positive (n)i 45+17 (4) 21+9 (3)
Titer at positive×106 (n)j 34+12 (4) 7+5 (3)
a All values are mean±SEM unless noted. 2 experiments for eyes except primary
model.
b Eye swab virus titers taken 3 days after primary infection of reactivation model
mice (anti-HSV antibodies administered on day of primary infection).
c Peak tear ﬁlm virus titer for all mice shedding virus after UV-B irradiation.
d P=0.005.
e Average number of days shedding for positive mice.
f Pb0.001.
g Trigeminal ganglia of latently infected (non-irradiated mice) were cultured on Vero
cells until viral plaques appeared; 1 experiment for TGs.
h Number of days in culture before appearance of plaques.
i Number of viral plaques observed on Vero monolayer on day of ﬁrst appearance of
plaques.
j Titer of HSV obtained from TG of positive wells plated on Vero cells.
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GKO mice, but day 21 was signiﬁcant (Fig. 1C). Virologic analysis
indicated that GKO mice had elevated tear ﬁlm titers at day 3 post
infection (normal 3161±652, n=15; GKO 7450±2118, n=15;
P=0.005). Viral titers for other time points, while elevated for GKO
mice, were not statistically signiﬁcant (data not shown). As antici-
pated, when delayed-type hypersensitivity (DTH) responses were
measured twoweeks post infectionwere signiﬁcantly reduced in GKO
mice as compared to normal B6 mice (Fig. 2). Thus the lack of IFNγ
during acute HSV-1 infection in mice with the B6 background did not
result in a signiﬁcantly altered disease phenotype.Fig. 5. Incidence of mice shedding virus following UV-B reactivation. The numbers of
mice used in this study were as follows: B6, n=35; GKO, n=30. Results indicate percent
mice shedding virus at that time point. Percent GKO mice shedding virus exceeded B6
on days 5 to 9 (P=0.003 to 0.045). Mean number of days shedding virus was GKO=4.25,
B6=2.0, (P=0.002). ○, B6 latently infected; ●, GKO latently infected.Next we examined the role of IFNγ in recurrent HSK. In this model,
we ocularly infect both normal and IFN-γ knock out (GKO) C57BL/6
mice with HSV-1 McKrae strain with concurrent administration of
protective anti-HSV antibodies. These antibodies have been shown to
prevent mortality while preserving corneal clarity. Five weeks after
infection, eyes of latently infected normal C57BL/6 and GKOmicewere
UV-B irradiated andmonitored for signs of ocular disease. Examination
of corneal opacity (Fig. 3A) and neovascularization (Fig. 3B) surpris-
ingly revealed that GKO mice displayed increased or similar disease
scores as compared to normal mice at all time points measured.
Differences in disease were more pronounced when blepharitis was
examined. GKO mice displayed increased severity (Fig. 4A) and
incidence (Fig. 4B) compared to normal mice from days 8 to 23.
Interestingly, when the corneas of representative mice from these
groups were examined histologically by H & E staining, the inﬂamma-
tory inﬁltrate was not signiﬁcantly different between wild-type and
GKO mice at Day 7 and 11 post UV-B irradiation (data not shown).
Post UV-B virus shedding in tears was assessed along with ocular
disease. The reactivation rate was greater for GKO mice (80%) than
normal mice (60%), but this difference did not prove to be statisticallyFig. 6. Analysis of genome copies in latently infected trigeminal ganglia. Real-time PCR
for the HSV-1 tk gene was performed on individual trigeminal ganglia from latently
infected mice. All samples were normalized to the single-copy mouse adipsin gene. The
data are reported as the logarithmic mean of the number of genome copies per
trigeminal ganglion. Trigeminal ganglia from latently infected mice (n=8 for all groups)
were dissociated from a single-cell suspension and then plated in twofold dilutions.
Fig. 7. Delayed-type hypersensitivity (DTH) responses 2 weeks following UV-B induced
reactivation. Following UV-B reactivation, mice were tested for DTH responses. The
numbers of mice used in this study were as follows: B6 infected, n=35; B6 naive, n=5;
GKO infected, n=30; GKO, n=5. Results indicate mean±SEM. *P=0.001 infected vs.
naive. **P=0.022 infected B6 vs. infected GKO.
49T.L. Keadle et al. / Virology 380 (2008) 46–51signiﬁcant (PN.05). However, virus was shed signiﬁcantly longer in
GKO eyes than in normal eyes with detectable virus found in GKOmice
up to Day 10 while virus could not be found in normal eyes beyond
Day 5 post UV-B (Fig. 5). In addition, peak virus shedding occurred
later in GKO mice (normal 3.09±0.211 versus GKO 4.79±0.38 days;
Table 1) and virus titers were greater in GKO than in normal mice
(normal 1716±781, GKO 44,643±15,593 Table 1). Because differences
in viral titer could have been the direct result of increased viral load in
the trigeminal ganglia of GKO vs. normal mice we decided to perform
real-time PCR analysis of trigeminal ganglia to determine relative
genome copies in these mouse strains following re-establishment of
latency after reactivation. Results of such analyses did not reveal
signiﬁcant differences in genome loads between latently infected
normal and GKO mice (Fig. 6). These data argue that differences in
viral shedding following UV-B-induced reactivation are likely not due
to increased viral load in trigeminal ganglia of GKO mice.
To functionally evaluate the lack of IFNγ in GKO mice, we again
performed DTH testing on mice two weeks after the reactivation
stimulus. As shown in Fig. 7, DTH responses in latently infected GKO
mice were signiﬁcantly less than that of normal latently infected mice
but were signiﬁcantly greater than that of naive control mice.
Discussion
This work examines for the ﬁrst time the role of IFNγ in recurrent
HSK using KO mice of the C57BL/6 background. Since mouse strains
are known to vary in susceptibility to HSV infection (Streilein et al.,
1997), we also included a study of primary HSK in C57BL/6 mice as the
most relevant comparison. Our ﬁndings highlight the importance of
IFNγ in controlling viral replication, while demonstrating the
redundancy of IFNγ in generating immunopathologic lesions in GKO
mice.
IFNγ control of viral replication in primary HSK was ﬁrst
demonstrated for GKO mice on the BALB/c background (Bouley
et al., 1995). These ﬁndings were extended to include the ability of
virus to establish latency in trigeminal ganglia, in which the viral load
was similar for normal and GKO mice as well as their ability to
reactivate (Lekstrom-Himes et al., 2000). In contrast to the Lekstrom-
Himes report for primary infection (Lekstrom-Himes et al., 2000), we
observed higher post infection tear ﬁlm virus titers in GKO eyes
compared to normal C57BL/6 eyes (Table 1).
In the ocular reactivation model, viral growth is a more complex
issue, because these mice have already been exposed to virus during
primary infection. Thus, factors to consider include: 1) Local immune
responses in the trigeminal ganglia that will restrict both viral
reactivation and the ability of virus to trafﬁc from the trigeminal
ganglia to the periphery (Liu et al., 2001; Khanna et al., 2003, Mikloska
and Cunningham 2001). 2) A cornea that possesses T cells that arelikely able to respond to HSV-1 (Stumpf et al., 2001). 3) Circulating
HSV-1 speciﬁc cells and antibodies that will migrate to the cornea
upon re-emergence of virus (Miller et al., 1996; Stumpf et al., 2001).
Consequently, the ﬁrst hurdle that the virus must overcome is the
presence of CD8+ T cells and their production of IFNγ in latently
infected trigeminal ganglia (Liu et al., 1996; Liu et al., 2001; Khanna
et al., 2003). Therefore, in order to compare shedding of virus at the
cornea, one must presuppose relative equivalent latency in trigeminal
ganglia and the absence of signiﬁcant ganglion-level IFNγ effects on
reactivation from latency. Our data suggests that is the case. First, day
3 postinfection tear ﬁlm titers are the same for normal and GKO mice
later used in reactivation studies (see Table 1). Second, in vitro
ganglionic reactivation rates and titers were not different between
groups (see Table 1). Third, for normal and GKO groups, an equal
number of days was required for virus to appear in in vitro ganglia
explant cultures, as well as, post UV-B irradiation tear ﬁlms (Days to
Positive Eye Swab, Table 1). Finally, the number of latent genomes in
the trigeminal ganglia of normal and GKO mice was relatively
equivalent for wild-type and GKO mice that had re-established
latency following reactivation (see Fig. 6). These ﬁndings are similar
to that of Lekstrom-Himes et al. who reported equivalent latent HSV
genome copies in the trigeminal ganglia of C57BL/6 normal and GKO
mice after primary infection (Lekstrom-Himes et al., 2000). On this
basis, we conclude that IFNγ control of viral replication during
reactivation is exerted primarily at the level of the eye and skin. Thus,
while both normal and GKO eyes took about 2.5 days to begin
shedding virus, eyes lacking IFNγ (GKO) shed longer (days shedding,
Table 1) with higher virus titers (Table 1). These ﬁndings are in accord
with a proposed role of IFNγ in limiting replication of newly re-
activated virus rather than limiting reactivation itself (Cantin et al.,
1999a,b; Presti et al., 1998; He et al., 1999). It should also be pointed
out that while we generally never detect spontaneous corneal
shedding of virus from B6 mice we did detect spontaneous corneal
shedding in 2 of the 70 total B6-GKO mice that were latently infected.
IFN-γ appears to be superﬂuous for the generation of corneal
lesions in GKO mice during acute infection (see Fig. 1). This ﬁnding is
consistent with previous reports of primary infection of both BALB/c
GKO mice (Bouley et al., 1995) and C57BL/6 GKO mice (Ghiasi et al.,
2000). These ﬁndings were later conﬁrmed when CD154 KO mice
were infected and in spite of signiﬁcant reductions in IFNγ following
HSV-1 infection, their disease was equivalent to that seen in normal
BALB/c mice (Xu et al., 2004). Those authors suggested that while
primary HSK does require the presence of Th1 cells that other Th1
cytokines could compensate for the lack of IFNγ (Bouley et al., 1995).
Support for this hypothesis has recently been put forward by studies
comparing Stat4 KO mice to normal mice, in which Stat4 KO mice
displayed signiﬁcantly reduced disease (Banerjee et al., 2007). Stat 4 is
intracellular protein whose activation polarizes T cells to a Th1
phenotype and so disruption of this pathway signiﬁcantly reduces the
ability of these cells to take on a Th1 phenotype and the accompanying
production of all Th1-associated cytokines (Kaplan, 2005).
Here we have examined HSK in both a primary infection model as
well as a recurrent model of HSK in C57BL/6 mice utilizing equal virus
infection loads. We found that GKOmice had no difﬁculty manifesting
corneal opacity and neovascularization equal to, or even greater than
controls (Figs. 1, 3), after primary and recurrent ocular infection.
Interestingly, we saw an even more pronounced increase in
blepharitis following UV-B irradiation (see Fig. 4). This could be due
to either more efﬁcient spread of virus to perioccular tissues in the
absence of IFNγ or that once again mice lacking IFNγ have impaired
ability to clear virus in the periphery leading to increased inﬂamma-
tion due to prolonged and increased levels of virus. We are currently
performing studies to address these alternatives.
The presence of increased corneal lesions in the absence of IFNγ
during recurrent HSKmay reﬂect the inﬂuence of other compensatory
pro-inﬂammatory cytokines (e.g. IL-2, Hendricks et al., 1992), and
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(Bouley et al., 1995), and/or alternative IFNγ receptor ligands (Cantin
et al., 1999a,b). Indeed, reduced but signiﬁcant DTH responses in GKO
mice (Figs. 2 and 6) suggest that other HSV-directed pro-inﬂammatory
immune responses are at work in these mice. Absent immunologic
causes, the most likely explanation for HSK lesions in GKO mice is the
virus itself. Thus, increased ocular disease could result from higher
levels of virus (Table 1) and prolonged viral replication (Fig. 5, Table 1)
that exacerbates corneal damage. Likewise, increased blepharitis is
probably the result of uncontrolled virus replication in the skin as
previously reported (Bouley et al., 1995; He et al., 1999; Smith et al.,
1994).
In summary, we have afﬁrmed the importance of IFNγ in
controlling viral replication in the mouse model of recurrent ocular
HSV. Importantly, viral and immunologic factors other than IFNγmay
contribute to the genesis of HSK in both primary and recurrent ocular
HSV infection.
Methods
Virus and tissue culture
The virus used in these studies was the human isolate HSV-1
McKrae strain. A plaque-puriﬁed stock was grown and assayed on
VERO cells in minimum essential medium with Earle's balanced salts
(MEM-EBS) containing 5% fetal bovine serum, 100 U/ml Penicillin and
100 μg/ml Streptomycin. Cells were cultured at 37 °C in a humidiﬁed
incubator containing 5% CO2. To detect recurrent ocular virus shedding
at the cornea, eye swabs were performed by the same person, who
swipes each eye 10 times in order to maintain consistency of results.
The material from eye swabs was plated onto VERO cells, which were
then monitored for cytopathic effects (CPE) 48 and 96 h later. Those
swabs demonstrating CPE were titered in using serial dilution and
standard plaque assays (Keadle et al., 1997). For in vitro reactivation
studies, trigeminal ganglia were removed from latently infected (non-
irradiated) mice, physically disrupted and placed into 2 wells of a 6-
well plate containing a VERO cell monolayer. At the ﬁrst appearance of
viral plaques, a visual count of plaques was performed (both wells)
and the remaining ganglia tissue, VERO cells andmediawere removed
from the 2 wells for each trigeminal ganglia and combined. A virus-
containing supernatant was obtained after 3 freeze/thaw cycles,
sonication, and centrifugation of the well contents. Virus titers in the
supernatant were then obtained by serial dilution and plaque assays.
Infection of mice
Investigations with mice conformed to the Association for
Research in Vision and Ophthalmology (ARVO) Statement for the
Use of Animals in Ophthalmic and Vision Research. In the reactivation
model, 6–12 week old C57BL/6 (B6), or C57BL/6 background IFN γ (IFN
γ −/−) gene knock out (GKO) mice (Jackson Laboratories; Strain
B6129S7-Ifngtm1Ts/J) were infected on the scariﬁed cornea with 106
PFU HSV-1 McKrae strain as previously described (Keadle et al., 1997).
Eachmouse received an intra-peritoneal (IP) injection of 0.5ml pooled
human serum (Sigma Chemicals, St. Louis MO; ED50 for virus
neutralization=1:1600) concurrent with infection. Administration of
anti-HSV antibodies at the time of ocular infection has been shown to
protect mice from death and corneal disease during primary infection,
while allowing for the establishment of latency and subsequent
reactivation of virus after corneal UV-B exposure. These antibodies are
undetectable at the time of UV-B irradiation 5 weeks after primary
infection. HSV positive eye swabs obtained three days after treatment
conﬁrm primary infection.
In primary infection studies, B6 and GKO mice were infected with
5×105 PFU of the McKrae strain of HSV-1 as described above without
administration of human serum.UV-B irradiation and virus reactivation
The eyes of all latently infected mice were examined for corneal
opacity before irradiation, and only animals with clear corneas were
used. At least 5 weeks after primary infection, the eyes of latently
infected and control mock-infected mice (B6 and GKO) were exposed
to 250 mJ/cm2 of UV-B light using a TM20 Chromato-Vu transillumi-
nator (UVP, Inc., San Gabriel, CA), which emits UV-B at a peak
wavelength of 302 nm. Before (day 0), and on days 1 to 10+day 14
post-UV-B irradiation, the eyes of mice were swabbed with surgical
spears (Weckcel, Xomed-Treace, Jacksonville, FL) saturated with tissue
culture medium. The swab material was cultured on VERO cells, as
described above, in order to detect recurrent virus shedding from the
cornea. Reactivationwas deﬁned as the ﬁnding of any HSV positive eye
swab on days 1 to 14 post-UV-B exposure, with day 0 swabs serving as
a control. Normal C57BL/6 mice experience low and variable virus
shedding (5–40%) with accompanying low levels of corneal pathology
(Foster et al., 1986; Keadle et al., 2002).
Clinical evaluation
On the designated days after primary infection UV-B irradiation of
latently infected mice, a masked observer examined mouse eyes
through a binocular-dissecting microscope in order to score clinical
disease. Stromal opaciﬁcation was rated on a scale of 0 to 4, where 0
indicates clear stroma, 1 indicates mild stromal opaciﬁcation, 2
indicates moderate opacity with discernible iris features, 3 indicates
dense opacity with loss of deﬁned iris detail except pupil margins, and
4 indicates total opacity with no posterior view. Neovascularization
was rated on a scale from 0 to 2 for 4 corneal quadrants, with a
maximum score of 8. A score of 0 indicates no new blood vessel
incursion into the cornea, a score of 1 indicates blood vessel incursion
up to 50% of the distance from the corneal limbus to the center of the
pupil, and a score of 2 indicates blood vessel growth traversing more
than 50% of the distance between limbus and pupil. Blepharitis was
scored from 0 to 2 where 0 is normal eye lid morphology and 2 is
necrotizing dermatitis.
Real-time PCR analysis for herpes genome
DNA was isolated using a DNeasy tissue preparation kit (Qiagen,
Valencia, CA). The number of latent genomes per trigeminal ganglia
was determined by real-time PCR essentially as described (Strand and
Leib 2004). Brieﬂy, a 70 bp fragment of the thymidine kinase (tk) gene
was ampliﬁed from trigeminal ganglia DNA and 10-fold dilutions of
HSV-1 bacterial artiﬁcial chromosome DNA, 17–49 BAC (Gierasch et
al., 2006). BAC DNA was used to generate a standard curve to
determine the number of genome copies per trigeminal ganglion
since BAC DNA models the episomal, latent genome. To control for
total DNA content of each sample, the single-copy mouse adipsin gene
was ampliﬁed in each sample along with dilutions of mouse genomic
DNA to generate a standard curve. The values for tk copy number were
normalized to the lowest value of mouse adipsin copy number to yield
the normalized genome copy per ganglion, which were expressed on
a log scale.
Delayed type hypersensitivity (DTH) responses
DTH responses were measured in uninfected (naïve) and infected
mice, 2 weeks after primary infection or UV-B irradiation of latently
infected animals. As previously described, 5×106 PFU (before
inactivation) of UV-inactivated HSV-1 McKrae in 30 μl of medium
was injected into the right rear foot pad of each mouse (Keadle et al.,
1997). The left rear foot pad was injected with the same amount of
virus-free tissue culture medium. Foot pad swelling was measured
with a micrometer (Mitutoyo Manufacturing, Tokyo, Japan)
51T.L. Keadle et al. / Virology 380 (2008) 46–51immediately prior to and 24 h after injection. HSV-speciﬁc footpad
swelling was determined by the formula: [right foot pad swelling at
24 h−right footpad swelling before injection]− [left footpad swelling
at 24 h after injection− left footpad swelling before injection].
Statistical analysis
All statistical analyses were performed with the aid of Sigma Stat
for Windows version 2.0 (Jandel, Corte Madera, CA). The Student's T
test and theMann–Whitney rank sum test were used as appropriate to
analyze opacity, DTH responses, and virus titer data Fisher's exact or
Chi square tests were used to compare reactivation rates.
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